Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Meiji Seika
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zinapar
(darinaparsin) / Solasia, Meiji Seika, Nippon Kayaku
ARCT-021
/ Arcturus Therap, CSL Behring, Meiji Seika
AM3301
/ Kemin, Meiji Seika
Aimmugen
(freeze-dried inactivated tissue culture hepatitis A vaccine) / Astellas, Meiji Seika, Mitsubishi Tanabe
Byclot
(freeze-dried activated human blood coagulation factor VIIa concentrate containing factor X) / Meiji Seika
ME3183
/ Meiji Seika
TAC-302
/ Otsuka, Meiji Seika
recombinant human matrix metalloproteinase
(KTP-001) / Teijin, Meiji Seika
